World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
57
Citations
10754
World Ranking
2157
National Ranking
51

Tom van Wezel publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Tom van Wezel sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 221 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Tom van Wezel D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Tom van Wezel sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 57 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Tom van Wezel is affiliated with Leiden University Medical Center in the Netherlands, specializing in research at the intersection of medicine, biochemistry, genetics, and molecular biology. Their work spans several key fields of study, notably pathology and forensic medicine, cancer research, oncology, genetics, and pulmonary and respiratory medicine.

Their research contributions focus predominantly on cancer genomics and diagnostics, addressing genetic factors in colorectal cancer, lymphoma diagnosis and treatment, BRCA gene mutations in cancer, and studies related to colorectal and lung cancer treatments, as well as ovarian cancer diagnosis and treatment.

Tom van Wezel's recent publications illustrate the scope and detail of their research. Key papers include:

  • "Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing," 2020, Journal of Thoracic Oncology
  • "Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing," 2020, Leukemia
  • "Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer," 2021, JNCI Journal of the National Cancer Institute
  • "IGLV3-21 *01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling," 2020, Proceedings of the National Academy of Sciences
  • "Germline MBD4 deficiency causes a multi-tumor predisposition syndrome," 2022, The American Journal of Human Genetics

Their collaborations reflect sustained partnerships with frequent coauthors including Maartje Nielsen, Hans Morreau, Dina Ruano, Diantha Terlouw, and Carli M.J. Tops, highlighting a networked approach to cancer and molecular genetic research.

Major publication venues where Tom van Wezel's work frequently appears are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Modern Pathology
  • Cancers
  • Blood
  • Annals of Oncology

Tom van Wezel has contributed extensively to understanding the complexities of genetic mutations and their impact on various cancers. Their research methodology often integrates cutting-edge sequencing technologies to enhance diagnostic precision and expand knowledge on hereditary risk factors and tumor predisposition syndromes. This multidisciplinary focus supports advancements across oncology, molecular diagnostics, and genetics, maintaining a strong clinical relevance within Leiden University Medical Center's medical research framework.

Best Publications

  • A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3

    Ian P.M. Tomlinson;Emily Webb;Luis Carvajal-Carmona;Peter Broderick

  • Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome

    Twinkal C. Pansuriya;Ronald van Eijk;Pio d'Adamo;Maayke A. J. H. van Ruler

  • E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines

    M. Lombaerts;T. Van Wezel;K. Philippo;J. W. F. Dierssen

  • Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer.

    Jarno Drost;Ruben van Boxtel;Francis Blokzijl;Tomohiro Mizutani

  • Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers.

    Claudia A.L. Ruivenkamp;Tom van Wezel;Carlo Zanon;Alphons P.M. Stassen

  • Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study

    Enric Domingo;Enric Domingo;Luke Freeman-Mills;Emily Rayner;Mark Glaire

  • A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 ( REL ), 8q24.21 and 10p14 ( GATA3 )

    Victor Enciso-Mora;Peter Broderick;Yussanne Ma;Ruth F. Jarrett

  • Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.

    Ronald van Eijk;Jappe Licht;Melanie Schrumpf;Mehrdad Talebian Yazdi

  • Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK.

    Philip W. Voorneveld;Liudmila L. Kodach;Rutger J. Jacobs;Nalan Liv

  • Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell ‘stemness’ via the bone morphogenetic protein pathway

    Liudmila L Kodach;Rutger J Jacobs;Philip W Voorneveld;Manon E Wildenberg

  • Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor Phenotype

    Judith E. Grolleman;Richarda M. de Voer;Fadwa A. Elsayed;Maartje Nielsen

  • Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.

    Judith N Kloth;Jan Oosting;Tom van Wezel;Karoly Szuhai

  • Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer.

    Fadwa A Elsayed;C Marleen Kets;Dina Ruano;Brendy van den Akker

  • Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer.

    Marlies S. Reimers;Esther Bastiaannet;Ruth E. Langley;Ronald van Eijk

  • Genomic Characterization of Vulvar (Pre)cancers Identifies Distinct Molecular Subtypes with Prognostic Significance.

    Linda S. Nooij;Natalja T. ter Haar;Dina Ruano;Natalia Rakislova

  • Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers

    Anne M. L. Jansen;Tom van Wezel;Brendy E. W. M. van den Akker;Marina Ventayol Garcia

  • HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression

    Jan Willem F Dierssen;Noel F C C de Miranda;Soldano Ferrone;Marjo van Puijenbroek

  • The colorectal cancer risk at 18q21 is caused by a novel variant altering SMAD7 expression

    Alan M. Pittman;Silvia Naranjo;Emily Webb;Peter Broderick

  • Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays.

    Esther H. Lips;Jan Willem F. Dierssen;Ronald van Eijk;Jan Oosting

  • Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas

    C. J. Haven;M. van Puijenbroek;M. H. Tan;B. T. Teh

Frequent Co-Authors

Hans Morreau
Hans Morreau Leiden University Medical Center
Frederik J. Hes
Frederik J. Hes Vrije Universiteit Brussel
Juul T. Wijnen
Juul T. Wijnen Leiden University Medical Center
Hans F. A. Vasen
Hans F. A. Vasen Leiden University
Ian Tomlinson
Ian Tomlinson University of Oxford
Sergi Castellví-Bel
Sergi Castellví-Bel Clínic Barcelona
Richard S. Houlston
Richard S. Houlston Institute of Cancer Research
Judith V.M.G. Bovée
Judith V.M.G. Bovée Leiden University Medical Center
Cornelis J.H. van de Velde
Cornelis J.H. van de Velde Leiden University Medical Center
Antoni Castells
Antoni Castells University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in expanding your molecular biology knowledge into healthcare or nursing, there are several flexible online degree options in the USA. Many students transition from laboratory research to clinical or patient-focused roles via accelerated nursing programs.

For those looking to earn credentials quickly, consider the fastest rn to bsn program online. This route suits students who already hold an RN license and want to advance their careers efficiently. Additionally, professionals with an ADN can continue their education through adn to np programs online, combining molecular biology fundamentals with advanced nursing skills.

Thinking of a direct jump into nursing, even without prior experience? Consider enrolling in msn direct entry programs online. These programs offer intensive study and fast-track entry into advanced nursing.

When evaluating schools, compare quality and affordability. The best value nursing education online wgu review can help you choose a reputable institution for online nursing studies.

Best Scientists Citing Tom van Wezel

Trending Scientists

Recently Published Articles